Hypertrophy

Citations 401-410 of 489 total displayed.

Past content (since Jan 1999):

Clinical Investigations and Reports
Mechanisms of Coronary Microcirculatory Dysfunction in Patients With Aortic Stenosis and Angiographically Normal Coronary Arteries: Kim Rajappan, Ornella E. Rimoldi, David P. Dutka, Ben Ariff, Dudley J. Pennell, Desmond J. Sheridan, and Paolo G. Camici
Circulation 2002;105:470-476, doi:10.1161/hc0402.102931 [Abstract] [Full text]

Articles
Peroxisome Proliferator--Activated Receptor ${alpha}$ Gene Regulates Left Ventricular Growth in Response to Exercise and Hypertension: Yalda Jamshidi, Hugh E. Montgomery, Hans-Werner Hense, Saul G. Myerson, Ines Pineda Torra, Bart Staels, Michael J. World, Angela Doering, Jeanette Erdmann, Christian Hengstenberg, Steve E. Humphries, Heribert Schunkert, and David M. Flavell
Circulation published January 22, 2002, doi:10.1161/hc0802.104535 [Abstract]

Articles
Relationship Between Treatment-Induced Changes in Left Ventricular Mass and Blood Pressure in Black African Hypertensive Patients. Results of the Baragwanath Trial: Daniel Skudicky, Pinhas Sareli, Elena Libhaber, Geoffrey Candy, Ivo Radevski, Zdravska Valtchanova, Elizabeth Tshele, Lutgarde Thijs, Ji-Guang Wang, and Jan A. Staessen
Circulation published January 22, 2002, doi:10.1161/hc0702.104162 [Abstract]

Articles
Peroxisome Proliferator--Activated Receptor ${alpha}$ Gene Regulates Left Ventricular Growth in Response to Exercise and Hypertension: Yalda Jamshidi, Hugh E. Montgomery, Hans-Werner Hense, Saul G. Myerson, Ines Pineda Torra, Bart Staels, Michael J. World, Angela Doering, Jeanette Erdmann, Christian Hengstenberg, Steve E. Humphries, Heribert Schunkert, and David M. Flavell
Circulation published January 22, 2002, doi:10.1161/hc0802.104535 [Abstract]

Brief Rapid Communications
Neutral Endopeptidase Is Activated in Cardiomyocytes in Human Aortic Valve Stenosis and Heart Failure: Jens Fielitz, Andreas Dendorfer, Reinhard Pregla, Elisabeth Ehler, Heinz R. Zurbrügg, Jozef Bartunek, Roland Hetzer, and Vera Regitz-Zagrosek
Circulation 2002;105:286-289, doi:10.1161/hc0302.103593 [Abstract] [Full text]

Brief Rapid Communications
Pivotal Role of a gp91^phox-Containing NADPH Oxidase in Angiotensin II-Induced Cardiac Hypertrophy in Mice: Jennifer K. Bendall, Alison C. Cave, Christophe Heymes, Nicholas Gall, and Ajay M. Shah
Circulation 2002;105:293-296, doi:10.1161/hc0302.103712 [Abstract] [Full text]

Basic Science Reports
Genetic Alterations That Inhibit In Vivo Pressure-Overload Hypertrophy Prevent Cardiac Dysfunction Despite Increased Wall Stress: Giovanni Esposito, Antonio Rapacciuolo, Sathyamangla V. Naga Prasad, Hideyuki Takaoka, Steven A. Thomas, Walter J. Koch, and Howard A. Rockman
Circulation 2002;105:85-92, doi:10.1161/hc0102.101365 [Abstract] [Full text]

Correspondence
Myocardial Dysfunction in Hypertrophic Cardiomyopathy • Response: Houman Ashrafian, Hugh Watkins, Sherif F. Nagueh, Linda L. Bachinski, Denise Meyer, Rita Hill, William A. Zoghbi, James W. Tam, Miguel A. Quiñones, Robert Roberts, and A.J. Marian
Circulation 2001;104:e165 [Full text]

Basic Science Reports
Impaired Endothelial Regulation of Ventricular Relaxation in Cardiac Hypertrophy: Role of Reactive Oxygen Species and NADPH Oxidase: Philip A. MacCarthy, David J. Grieve, Jian-Mei Li, Christina Dunster, Frank J. Kelly, and Ajay M. Shah
Circulation 2001;104:2967-2974, doi:10.1161/hc4901.100382 [Abstract] [Full text]

Clinical Cardiology: New Frontiers
New Concepts in Hypertrophic Cardiomyopathies, Part II: Robert Roberts and Ulrich Sigwart
Circulation 2001;104:2249-2252, doi:10.1161/hc4301.097430 [Full text]

Subspecialty Collections Home

Show Hypertrophy
collections from other journals.